Cerus Corporation (CERS)
USD 1.29
(-7.86%)
USD 1.29
(-7.86%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 143.15 Million USD | 16.16% |
| 2022 | 121.17 Million USD | 4.17% |
| 2021 | 116.32 Million USD | 6.62% |
| 2020 | 109.09 Million USD | 1.53% |
| 2019 | 107.45 Million USD | 27.53% |
| 2018 | 84.26 Million USD | 7.25% |
| 2017 | 78.56 Million USD | 0.49% |
| 2016 | 78.18 Million USD | 8.84% |
| 2015 | 71.83 Million USD | 20.37% |
| 2014 | 59.67 Million USD | 31.58% |
| 2013 | 45.35 Million USD | 35.88% |
| 2012 | 33.37 Million USD | 9.68% |
| 2011 | 30.43 Million USD | 13.39% |
| 2010 | 26.83 Million USD | -5.48% |
| 2009 | 28.39 Million USD | -24.02% |
| 2008 | 37.36 Million USD | -23.71% |
| 2007 | 48.98 Million USD | 12.55% |
| 2006 | 43.51 Million USD | 29.09% |
| 2005 | 33.71 Million USD | -10.99% |
| 2004 | 37.87 Million USD | -40.35% |
| 2003 | 63.5 Million USD | -6.3% |
| 2002 | 67.76 Million USD | 16.01% |
| 2001 | 58.41 Million USD | 37.06% |
| 2000 | 42.61 Million USD | 52.75% |
| 1999 | 27.9 Million USD | -18.66% |
| 1998 | 34.3 Million USD | 45.96% |
| 1997 | 23.5 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 34.28 Million USD | 10.91% |
| 2024 Q3 | 31.79 Million USD | -6.31% |
| 2024 Q2 | 33.94 Million USD | -0.99% |
| 2023 Q4 | 30.91 Million USD | 21.41% |
| 2023 Q1 | 31.43 Million USD | -8.86% |
| 2023 FY | 140.75 Million USD | 16.16% |
| 2023 Q2 | 30.85 Million USD | -1.85% |
| 2023 Q3 | 25.45 Million USD | -17.47% |
| 2022 Q4 | 34.48 Million USD | 17.48% |
| 2022 FY | 121.17 Million USD | 4.17% |
| 2022 Q2 | 28.11 Million USD | -3.77% |
| 2022 Q3 | 29.35 Million USD | 4.41% |
| 2022 Q1 | 29.21 Million USD | 6.81% |
| 2021 Q2 | 30.56 Million USD | 6.37% |
| 2021 FY | 116.32 Million USD | 6.62% |
| 2021 Q4 | 27.35 Million USD | -7.83% |
| 2021 Q3 | 29.67 Million USD | -2.9% |
| 2021 Q1 | 28.73 Million USD | -5.37% |
| 2020 Q4 | 30.36 Million USD | 13.98% |
| 2020 Q2 | 26.4 Million USD | 2.78% |
| 2020 Q3 | 26.63 Million USD | 0.87% |
| 2020 FY | 109.09 Million USD | 1.53% |
| 2020 Q1 | 25.69 Million USD | -8.34% |
| 2019 Q4 | 28.03 Million USD | 2.33% |
| 2019 Q1 | 25.14 Million USD | 6.79% |
| 2019 FY | 107.45 Million USD | 27.53% |
| 2019 Q2 | 26.89 Million USD | 6.96% |
| 2019 Q3 | 27.39 Million USD | 1.87% |
| 2018 Q3 | 20.86 Million USD | 2.91% |
| 2018 Q2 | 20.27 Million USD | 3.48% |
| 2018 Q4 | 23.54 Million USD | 12.85% |
| 2018 Q1 | 19.58 Million USD | 9.06% |
| 2018 FY | 84.26 Million USD | 7.25% |
| 2017 Q2 | 21.36 Million USD | -0.17% |
| 2017 Q1 | 21.4 Million USD | 9.92% |
| 2017 Q3 | 17.83 Million USD | -16.56% |
| 2017 Q4 | 17.96 Million USD | 0.73% |
| 2017 FY | 78.56 Million USD | 0.49% |
| 2016 Q1 | 18.71 Million USD | 1.23% |
| 2016 Q2 | 21.01 Million USD | 12.29% |
| 2016 Q3 | 18.98 Million USD | -9.66% |
| 2016 Q4 | 19.47 Million USD | 2.59% |
| 2016 FY | 78.18 Million USD | 8.84% |
| 2015 FY | 71.83 Million USD | 20.37% |
| 2015 Q4 | 18.48 Million USD | -0.99% |
| 2015 Q3 | 18.67 Million USD | 7.76% |
| 2015 Q2 | 17.32 Million USD | -0.13% |
| 2015 Q1 | 17.34 Million USD | 9.31% |
| 2014 Q3 | 16.02 Million USD | 7.88% |
| 2014 Q1 | 12.92 Million USD | 6.85% |
| 2014 FY | 59.67 Million USD | 31.58% |
| 2014 Q4 | 15.87 Million USD | -0.95% |
| 2014 Q2 | 14.85 Million USD | 14.89% |
| 2013 Q1 | 9.6 Million USD | 6.59% |
| 2013 Q4 | 12.09 Million USD | -0.35% |
| 2013 Q3 | 12.14 Million USD | 5.47% |
| 2013 Q2 | 11.51 Million USD | 19.87% |
| 2013 FY | 45.35 Million USD | 35.88% |
| 2012 FY | 33.37 Million USD | 9.68% |
| 2012 Q4 | 9 Million USD | 10.24% |
| 2012 Q3 | 8.17 Million USD | -3.28% |
| 2012 Q2 | 8.44 Million USD | 7.77% |
| 2012 Q1 | 7.84 Million USD | 3.84% |
| 2011 Q2 | 8.25 Million USD | 11.72% |
| 2011 Q3 | 7.24 Million USD | -12.2% |
| 2011 Q4 | 7.55 Million USD | 4.21% |
| 2011 FY | 30.43 Million USD | 13.39% |
| 2011 Q1 | 7.38 Million USD | -0.18% |
| 2010 FY | 26.83 Million USD | -5.48% |
| 2010 Q2 | 6.54 Million USD | 0.43% |
| 2010 Q1 | 6.52 Million USD | -2.35% |
| 2010 Q4 | 7.39 Million USD | 16.14% |
| 2010 Q3 | 6.37 Million USD | -2.7% |
| 2009 Q1 | 8.11 Million USD | 3.68% |
| 2009 Q3 | 6.57 Million USD | -6.6% |
| 2009 Q2 | 7.03 Million USD | -13.3% |
| 2009 Q4 | 6.67 Million USD | 1.63% |
| 2009 FY | 28.39 Million USD | -24.02% |
| 2008 Q3 | 9.55 Million USD | -5.53% |
| 2008 FY | 37.36 Million USD | -23.71% |
| 2008 Q4 | 7.82 Million USD | -18.06% |
| 2008 Q2 | 10.1 Million USD | 2.27% |
| 2008 Q1 | 9.88 Million USD | 322.08% |
| 2007 Q3 | 12.51 Million USD | -44.04% |
| 2007 Q1 | 11.77 Million USD | 4.17% |
| 2007 Q4 | 2.34 Million USD | -81.28% |
| 2007 FY | 48.98 Million USD | 12.55% |
| 2007 Q2 | 22.35 Million USD | 89.96% |
| 2006 FY | 43.51 Million USD | 29.09% |
| 2006 Q3 | 10.3 Million USD | -14.98% |
| 2006 Q4 | 11.29 Million USD | 9.67% |
| 2006 Q1 | 9.79 Million USD | 9.38% |
| 2006 Q2 | 12.11 Million USD | 23.69% |
| 2005 Q1 | 7.47 Million USD | 1.67% |
| 2005 Q2 | 8.49 Million USD | 13.75% |
| 2005 Q3 | 8.78 Million USD | 3.41% |
| 2005 FY | 33.71 Million USD | -10.99% |
| 2005 Q4 | 8.95 Million USD | 1.95% |
| 2004 Q1 | 11.71 Million USD | -6.67% |
| 2004 Q2 | 11.63 Million USD | -0.61% |
| 2004 Q3 | 7.17 Million USD | -38.32% |
| 2004 Q4 | 7.34 Million USD | 2.34% |
| 2004 FY | 37.87 Million USD | -40.35% |
| 2003 Q3 | 15.98 Million USD | -9.04% |
| 2003 Q2 | 17.57 Million USD | 1.06% |
| 2003 Q4 | 12.54 Million USD | -21.51% |
| 2003 Q1 | 17.39 Million USD | -1.92% |
| 2003 FY | 63.5 Million USD | -6.3% |
| 2002 Q3 | 17.8 Million USD | 1.7% |
| 2002 Q1 | 14.72 Million USD | -4.59% |
| 2002 FY | 67.76 Million USD | 16.01% |
| 2002 Q2 | 17.5 Million USD | 18.92% |
| 2002 Q4 | 17.73 Million USD | -0.43% |
| 2001 Q2 | 14.74 Million USD | 7.64% |
| 2001 FY | 58.41 Million USD | 37.06% |
| 2001 Q4 | 15.43 Million USD | 6.12% |
| 2001 Q3 | 14.54 Million USD | -1.38% |
| 2001 Q1 | 13.69 Million USD | 6.59% |
| 2000 FY | 42.61 Million USD | 52.75% |
| 2000 Q1 | 8.95 Million USD | 13.39% |
| 2000 Q4 | 12.85 Million USD | 18.44% |
| 2000 Q3 | 10.84 Million USD | 8.91% |
| 2000 Q2 | 9.96 Million USD | 11.2% |
| 1999 Q3 | 7.4 Million USD | 8.82% |
| 1999 Q1 | 5.7 Million USD | -17.39% |
| 1999 FY | 27.9 Million USD | -18.66% |
| 1999 Q4 | 7.9 Million USD | 6.76% |
| 1999 Q2 | 6.8 Million USD | 19.3% |
| 1998 Q2 | 14.8 Million USD | 159.65% |
| 1998 Q1 | 5.7 Million USD | -9.52% |
| 1998 FY | 34.3 Million USD | 45.96% |
| 1998 Q3 | 6.9 Million USD | -53.38% |
| 1998 Q4 | 6.9 Million USD | 0.0% |
| 1997 Q3 | 5.7 Million USD | -3.39% |
| 1997 Q2 | 5.9 Million USD | 5.36% |
| 1997 FY | 23.5 Million USD | 0.0% |
| 1997 Q1 | 5.6 Million USD | 0.0% |
| 1997 Q4 | 6.3 Million USD | 10.53% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | -1175.437% |
| OrthoPediatrics Corp. | 137.01 Million USD | -4.478% |
| PetVivo Holdings, Inc. | 11.36 Million USD | -1160.071% |
| Talis Biomedical Corporation | 67.18 Million USD | -113.073% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | -473.86% |
| Inogen, Inc. | 236.08 Million USD | 39.363% |
| Spectral AI, Inc. | 20.86 Million USD | -586.134% |
| Nano-X Imaging Ltd. | 55.99 Million USD | -155.648% |
| CVRx, Inc. | 76.14 Million USD | -88.011% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -3957.686% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | -1046.249% |
| Orthofix Medical Inc. | 667.42 Million USD | 78.551% |
| Venus Concept Inc. | 80.47 Million USD | -77.885% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | -153.022% |
| Bioventus Inc. | 409.91 Million USD | 65.077% |
| BrainsWay Ltd. | 28.01 Million USD | -410.939% |
| Envoy Medical, Inc. | 17.89 Million USD | -699.838% |
| electroCore, Inc. | 32.03 Million USD | -346.926% |
| IceCure Medical Ltd | 16.87 Million USD | -748.276% |
| Lucid Diagnostics Inc. | 42.43 Million USD | -237.375% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | -711.857% |
| MaxCyte, Inc. | 84.84 Million USD | -68.725% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | -1053.381% |
| Nexalin Technology, Inc. | 5.78 Million USD | -2376.149% |
| PAVmed Inc | 64.82 Million USD | -120.826% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | -180.267% |
| RxSight, Inc. | 103.85 Million USD | -37.848% |
| Sight Sciences, Inc. | 126.44 Million USD | -13.212% |
| SI-BONE, Inc. | 156.35 Million USD | 8.44% |
| TELA Bio, Inc. | 84.18 Million USD | -70.044% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | -104.344% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | 29.607% |
| LivaNova PLC | 843.54 Million USD | 83.029% |
| 908 Devices Inc. | 68.08 Million USD | -110.275% |
| Alphatec Holdings, Inc. | 483.59 Million USD | 70.398% |
| Nemaura Medical Inc. | 7.13 Million USD | -1905.308% |
| NeuroPace, Inc. | 75.29 Million USD | -90.123% |
| LENSAR, Inc. | 33.33 Million USD | -329.431% |
| Apyx Medical Corporation | 51.01 Million USD | -180.597% |
| Cutera, Inc. | 197.72 Million USD | 27.599% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | -477.68% |
| BioSig Technologies, Inc. | 28.53 Million USD | -401.77% |
| Anika Therapeutics, Inc. | 191.47 Million USD | 25.236% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | -296.991% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 82.884% |
| Axonics, Inc. | 270.2 Million USD | 47.019% |
| Outset Medical, Inc. | 198.77 Million USD | 27.98% |
| IRIDEX Corporation | 31.81 Million USD | -349.975% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | 20.566% |
| IRadimed Corporation | 30.12 Million USD | -375.238% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -1577.86% |
| INVO Bioscience, Inc. | 7.85 Million USD | -1722.866% |
| Telesis Bio, Inc. | 63.48 Million USD | -125.48% |
| Viemed Healthcare, Inc. | 98.45 Million USD | -45.404% |
| Varex Imaging Corporation | 224.8 Million USD | 36.319% |
| Quipt Home Medical Corp. | 148.66 Million USD | 3.708% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -1121.146% |
| Pulmonx Corporation | 112.68 Million USD | -27.038% |
| Dynatronics Corporation | 9.9 Million USD | -1344.839% |
| Modular Medical, Inc. | 17.52 Million USD | -716.675% |
| ReShape Lifesciences Inc. | 20.18 Million USD | -609.144% |
| Semler Scientific, Inc. | 38.94 Million USD | -267.592% |
| InMode Ltd. | 215.68 Million USD | 33.626% |
| Bruker Corporation | 1.07 Billion USD | 86.701% |
| Cytosorbents Corporation | 48.33 Million USD | -196.161% |
| DexCom, Inc. | 1.69 Billion USD | 91.535% |
| Align Technology, Inc. | 2.07 Billion USD | 93.107% |
| Viveve Medical, Inc. | 22.17 Million USD | -545.628% |
| ZimVie Inc. | 275.12 Million USD | 47.967% |
| Movano Inc. | 29.69 Million USD | -382.166% |
| Cytek Biosciences, Inc. | 137.27 Million USD | -4.286% |
| Nexalin Technology, Inc. | 5.78 Million USD | -2376.149% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -3957.686% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 76.177% |
| Profound Medical Corp. | 33.6 Million USD | -326.017% |
| Insulet Corporation | 939.9 Million USD | 84.769% |
| enVVeno Medical Corporation | 25.23 Million USD | -467.22% |
| Surmodics, Inc. | 98.69 Million USD | -45.045% |
| iCAD, Inc. | 22.22 Million USD | -544.117% |
| Nuwellis, Inc. | 22.61 Million USD | -533.065% |
| Biotricity, Inc. | 17.18 Million USD | -733.045% |
| iRhythm Technologies, Inc. | 445.88 Million USD | 67.894% |
| Aethlon Medical, Inc. | 12.27 Million USD | -1065.994% |
| InspireMD, Inc. | 22.95 Million USD | -523.769% |
| PAVmed Inc. | 64.82 Million USD | -120.826% |
| BIOLASE, Inc. | 34.66 Million USD | -313.015% |
| Beyond Air, Inc. | 61.7 Million USD | -132.018% |
| FONAR Corporation | 28.6 Million USD | -400.46% |
| AxoGen, Inc. | 149.33 Million USD | 4.139% |
| Vivani Medical, Inc. | 26.96 Million USD | -430.892% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | 19.163% |
| Inari Medical, Inc. | 448.59 Million USD | 68.088% |
| UFP Technologies, Inc. | 58.08 Million USD | -146.441% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -2805.167% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -2165.724% |
| Tenon Medical, Inc. | 16.96 Million USD | -743.676% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -1836.359% |
| Co-Diagnostics, Inc. | 44.1 Million USD | -224.594% |
| AdaptHealth Corp. | 1.07 Billion USD | 86.72% |
| Sintx Technologies, Inc. | 15.2 Million USD | -841.747% |
| NanoVibronix, Inc. | 4.97 Million USD | -2778.645% |
| Quanterix Corporation | 118.1 Million USD | -21.215% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -1121.146% |
| Sensus Healthcare, Inc. | 14.44 Million USD | -891.241% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | 63.543% |
| TransMedics Group, Inc. | 182.82 Million USD | 21.696% |
| ReWalk Robotics Ltd. | 28.06 Million USD | -410.084% |
| NeuroMetrix, Inc. | 11.09 Million USD | -1189.809% |
| Hyperfine, Inc. | 52.87 Million USD | -170.758% |
| Establishment Labs Holdings Inc. | 172 Million USD | 16.772% |
| Biomerica, Inc. | 6.97 Million USD | -1951.519% |
| Bone Biologics Corporation | 9.42 Million USD | -1418.354% |
| AVITA Medical, Inc. | 80.77 Million USD | -77.218% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | -1288.343% |
| Silk Road Medical, Inc | 186.35 Million USD | 23.182% |